HIV Diagnostics Market Analysis By Product (Antibody Tests, Viral Identification Assays, CD4 Testing, Viral Load Testing, Early Infant Diagnosis) And Segment Forecasts To 2022

Report ID: 978-1-68038-461-1
Number of Pages: 121
Format: Electronic (PDF)

Historical Data: 2013-2015
Industry: Healthcare

Market segmentation

Global HIV Diagnostics Product Outlook (Revenue, USD Million, 2012 - 2022)

Antibody Tests
- HIV-1 Screening Tests
  - ELISA/EIA
  - Home Access Dried Blood Spot
  - Rapid Tests (Dot plot, Agglutination Tests)
Viral Identification Assays
- P24 Antigen Test
- Qualitative PCR Tests
- Viral Culture
CD4 Testing
Viral Load Testing
Early Infant Diagnostics

Global HIV Diagnostics Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North America
  - The U.S.
    - U.S. HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
      - Antibody Tests
        
        HIV-1 Screening Tests
        
        ELISA/EIA
        
        Home Access Dried Blood Spot
        
        Rapid Tests (Dot plot, Agglutination Tests)
        
        HIV-1 Antibody Confirmatory Tests
        
        Western Blot Test
        
        Indirect Immunofluorescent Antibody Assay (IFA)
        
        Line Immunoassay
        
        RadioImmunoPrecipitation Assay (RIPA)
        
        HIV-2 & Group O Diagnostic Tests
        
        Blood Antibody Tests
        
        Dried Blood Spot (DBS) Test
        
        Others and (Oral, Urine)
      - Viral Identification Assays
        
        P24 Antigen Test
        
        Qualitative PCR Tests
        
        Viral Culture
      - CD4 Testing
      - Viral Load Testing
      - Early Infant Diagnostics

Europe
- Germany
  - Germany HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
    - Antibody Tests
      - HIV-1 Screening Tests
        
        ELISA/EIA
        
        Home Access Dried Blood Spot
        
        Rapid Tests (Dot plot, Agglutination Tests)
      - HIV-1 Antibody Confirmatory Tests
        
        Western Blot Test
        
        Indirect Immunofluorescent Antibody Assay (IFA)
        
        Line Immunoassay
        
        RadioImmunoPrecipitation Assay (RIPA)
      - HIV-2 & Group O Diagnostic Tests
        
        Blood Antibody Tests
        
        Dried Blood Spot (DBS) Test
        
        Others and (Oral, Urine)
    - Viral Identification Assays
      - P24 Antigen Test
      - Qualitative PCR Tests
      - Viral Culture
    - CD4 Testing
    - Viral Load Testing
    - Early Infant Diagnostics
- UK
  - UK HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
    - Antibody Tests
      - HIV-1 Screening Tests
        
        ELISA/EIA
        
        Home Access Dried Blood Spot
        
        Rapid Tests (Dot plot, Agglutination Tests)
      - HIV-1 Antibody Confirmatory Tests
        
        Western Blot Test
        
        Indirect Immunofluorescent Antibody Assay (IFA)
        
        Line Immunoassay
        
        RadioImmunoPrecipitation Assay (RIPA)
      - HIV-2 & Group O Diagnostic Tests
        
        Blood Antibody Tests
        
        Dried Blood Spot (DBS) Test
        
        Others and (Oral, Urine)
    - Viral Identification Assays
      - P24 Antigen Test
      - Qualitative PCR Tests
      - Viral Culture
    - CD4 Testing
    - Viral Load Testing
    - Early Infant Diagnostics
Asia Pacific
- Japan
  - Japan HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
    - Antibody Tests
      - HIV-1 Screening Tests
        
        ELISA/EIA
        
        Home Access Dried Blood Spot
        
        Rapid Tests (Dot plot, Agglutination Tests)
      - HIV-1 Antibody Confirmatory Tests
        
        Western Blot Test
        
        Indirect Immunofluorescent Antibody Assay (IFA)
        
        Line Immunoassay
        
        RadioImmunoPrecipitation Assay (RIPA)
      - HIV-2 & Group O Diagnostic Tests
        
        Blood Antibody Tests
        
        Dried Blood Spot (DBS) Test
        
        Others and (Oral, Urine)
    - Viral Identification Assays
      - P24 Antigen Test
      - Qualitative PCR Tests
      - Viral Culture
    - CD4 Testing
    - Viral Load Testing
    - Early Infant Diagnostics
- China
  - China HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
    - Antibody Tests
      - HIV-1 Screening Tests
        
        ELISA/EIA
        
        Home Access Dried Blood Spot
        
        Rapid Tests (Dot plot, Agglutination Tests)
      - HIV-1 Antibody Confirmatory Tests
        
        Western Blot Test
        
        Indirect Immunofluorescent Antibody Assay (IFA)
        
        Line Immunoassay
        
        RadioImmunoPrecipitation Assay (RIPA)
      - HIV-2 & Group O Diagnostic Tests
        
        Blood Antibody Tests
        
        Dried Blood Spot (DBS) Test
        
        Others and (Oral, Urine)
    - Viral Identification Assays
      - P24 Antigen Test
      - Qualitative PCR Tests
      - Viral Culture
    - CD4 Testing
    - Viral Load Testing
    - Early Infant Diagnostics
Latin America
- Brazil
  - Brazil HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
    - Antibody Tests
      - HIV-1 Screening Tests
        
        ELISA/EIA
        
        Home Access Dried Blood Spot
        
        Rapid Tests (Dot plot, Agglutination Tests)
      - HIV-1 Antibody Confirmatory Tests
        
        Western Blot Test
        
        Indirect Immunofluorescent Antibody Assay (IFA)
        
        Line Immunoassay
        
        RadioImmunoPrecipitation Assay (RIPA)
      - HIV-2 & Group O Diagnostic Tests
        
        Blood Antibody Tests
        
        Dried Blood Spot (DBS) Test
        
        Others and (Oral, Urine)
    - Viral Identification Assays
      - P24 Antigen Test
      - Qualitative PCR Tests
      - Viral Culture
    - CD4 Testing
    - Viral Load Testing
    - Early Infant Diagnostics
MEA
- South Africa
  - South Africa HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
    - Antibody Tests
      - HIV-1 Screening Tests
        
        ELISA/EIA
        
        Home Access Dried Blood Spot
        
        Rapid Tests (Dot plot, Agglutination Tests)
      - HIV-1 Antibody Confirmatory Tests
        
        Western Blot Test
        
        Indirect Immunofluorescent Antibody Assay (IFA)
        
        Line Immunoassay
        
        RadioImmunoPrecipitation Assay (RIPA)
      - HIV-2 & Group O Diagnostic Tests
        
        Blood Antibody Tests
        
        Dried Blood Spot (DBS) Test
        
        Others and (Oral, Urine)
    - Viral Identification Assays
      - P24 Antigen Test
      - Qualitative PCR Tests
      - Viral Culture
    - CD4 Testing
    - Viral Load Testing
    - Early Infant Diagnostics

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Application Segments Prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2012 to 2022
Revenue estimates for product up to 2022
Regional market size and forecast for product up to 2022
Revenue estimates for product segments up to 2022
Regional market size and forecast for segments up to 2022
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.